Cite
HARVARD Citation
Hoang, B. et al. (2021). Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism. Clinical and applied thrombosis/hemostasis. p. . [Online].